KTOS stock (NASDAQ: KTOS) planned sale of 4,692 shares filed

Rhea-AI Filing Summary

This Form 144 notice reports a planned sale of 4,692 shares of common stock through Morgan Stanley Smith Barney LLC, to be sold on or about 01/15/2026 on the NASDAQ market. The shares have an indicated aggregate market value of $570,078.00, while total common shares outstanding are listed as 168,840,708.

The securities to be sold were acquired on 06/04/2020 from the issuer via 4,189 performance stock units and 503 restricted stock units. The filing also notes prior Rule 10b5-1 sales for the same holder over the past three months: 1,567 shares sold on 12/15/2025 for gross proceeds of $119,515.09, and 1,408 shares sold on 11/17/2025 for $101,502.72. The signer represents they are not aware of undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4692	570078.00	168840708	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/04/2020	Performance Stock Units	Issuer			4189	06/04/2020	N/A
Common	06/04/2020	Restricted Stock Units	Issuer			503	06/04/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARIE C MENDOZA 10680 TREENA STREET, SUITE 600 SAN DIEGO CA 92131	Common	12/15/2025	1567	119515.09
10b5-1 Sales for MARIE C MENDOZA 10680 TREENA STREET, SUITE 600 SAN DIEGO CA 92131	Common	11/17/2025	1408	101502.72

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for KTOS disclose?

The Form 144 discloses a planned sale of 4,692 shares of common stock of the issuer, to be executed through Morgan Stanley Smith Barney LLC on or about 01/15/2026 on the NASDAQ exchange.

How many KTOS shares are planned to be sold and what is their market value?

The filing reports an intention to sell 4,692 common shares with an aggregate market value of $570,078.00 as stated in the securities information section.

How were the KTOS shares being sold under this Form 144 originally acquired?

The shares were acquired on 06/04/2020 from the issuer through 4,189 performance stock units and 503 restricted stock units, both with the same acquisition and payment date.

What recent KTOS share sales by this holder are disclosed in the past 3 months?

The form lists Rule 10b5-1 sales for MARIE C MENDOZA: 1,567 common shares sold on 12/15/2025 for $119,515.09, and 1,408 common shares sold on 11/17/2025 for $101,502.72.

How many KTOS common shares are outstanding according to this Form 144?

The securities information table states that 168,840,708 common shares are outstanding, providing context for the planned sale size.

What representation does the selling holder make in this KTOS Form 144?

By signing, the person for whose account the securities will be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Does this KTOS Form 144 mention reliance on a Rule 10b5-1 trading plan?

The form includes a section for the Date of Plan Adoption or Giving of Instruction, if relying on Rule 10b5-1, and references 10b5-1 sales in the table of securities sold during the past three months.